Fusion Pharmaceuticals
Fusion Pharmaceuticals's email is info@fusionpharma.com
and
Fusion Pharmaceuticals's phone number is (905) 525-9140
.
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre. Fusion’s deep radiochemistry expertise presents a technology platform that can be replicated to turn internalizing antibodies that have previously demonstrated limited clinical efficacy into highly effective cytotoxic drugs. Fusion’s ability to link the m...
read more
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company located in Hamilton, Ontario, Canada focused on becoming the leader in the targeted alpha therapy field. It is a spinout of the Centre for Probe Development and Commercialization (CPDC), a leading radiopharmaceutical research and GMP production centre. Fusion’s deep radiochemistry expertise presents a technology platform that can be replicated to turn internalizing antibodies that have previously demonstrated limited clinical efficacy into highly effective cytotoxic drugs. Fusion’s ability to link the most effective isotopes to the targeting antibody allows for the creation of optimized agents for both diagnostic imaging and radioimmunotherapy (Precision Medicine). Following positive tumor identification with the imaging agent, treatment with the antibody linked to a therapeutic isotope delivers a cytotoxic payload into the cancer cell. Fusion’s lead product candidate, FPX-01, is a precision RIT that is a product of this innovative approach. FPX-01 has been designed to internalize into targeted cancer cells and deliver a lethal and highly localized radioactive payload. The precise targeting of this radiolabeled antibody causes selective and extremely effective cytotoxicity of tumor cells at relatively low doses of radioactivity.
show less
Website | fusionpharma.com | |
Industry | Biotechnology | |
Location | Hamilton, Ontario, Canada | |
Employees | 54 | |
Founded | 2014 |
HQ | 1280 Main St. West NRB-A316 | |
Phone | (905) 525-9140 | |
info@fusionpharma.com | ||
Funding | 170,913,346 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | fusionpharma.com | |
Industry | Biotechnology | |
Location | Hamilton, Ontario, Canada | |
Employees | 54 | |
Founded | 2014 | |
linkedin.com/company/fusion-pharmaceuticals | ||
HQ | 1280 Main St. West NRB-A316 | |
Phone | (905) 525-9140 | |
info@fusionpharma.com | ||
Funding | 170,913,346 USD |
Top Competitors for Fusion Pharmaceuticals
Fusion Pharmaceuticals Questions
Where are Fusion Pharmaceuticals's headquarters?
Fusion Pharmaceuticals's headquarters are in 1280 Main St. West NRB-A316
What is Fusion Pharmaceuticals's phone number?
Fusion Pharmaceuticals's phone number is (905) 525-9140
What is Fusion Pharmaceuticals's official website?
Fusion Pharmaceuticals's website is fusionpharma.com
How many employees are working in Fusion Pharmaceuticals right now?
Fusion Pharmaceuticals has
54 employees.
View the Email and Phone Numbers for all 54 working at Fusion Pharmaceuticals.
What is Fusion Pharmaceuticals's industry?
Fusion Pharmaceuticals's industry is
Biotechnology
Who are Fusion Pharmaceuticals's top competitors?
Fusion Pharmaceuticals's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Fusion Pharmaceuticals's email address?
Fusion Pharmaceuticals's email address is info@fusionpharma.com
What are Fusion Pharmaceuticals's categories?
Fusion Pharmaceuticals's categories are Biopharma, Biotechnology, Clinical Trials, Medical, Pharmaceutical
What is Fusion Pharmaceuticals's location?
Fusion Pharmaceuticals's location is
Hamilton, Ontario, Canada
When was Fusion Pharmaceuticals's founded?
Fusion Pharmaceuticals's founding year is 2014
What is Fusion Pharmaceuticals's funding?
Fusion Pharmaceuticals's funding is 170,913,346 USD
What is Fusion Pharmaceuticals's current status?
Fusion Pharmaceuticals's current status is ipo
Top Fusion Pharmaceuticals Employees
Product Logistics And Distribution Manager
ldeguglielmo@stonehill.edu
+1617-439-5880
Senior Vice President Research
idussaul@gmail.com
+1805-551-0082
Head Of Clinical Operations
cwestfall@tolerx.com
+1857-305-3108
Senior Director Information Technology
tfox@keryx.com
+1212-531-5965
Associate Director, Business Development And Alliance Management
antonio.lepore@navigant.com
+1574-287-2831
Senior Director, Human Resources
sdaly1016@gmail.com
+1617-606-9653
Senior Clinical Project Manager
jlabagnara@dicerna.com
+1201-274-5260